These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7662077)
1. [Immunohistochemical detection of c-myc proto-oncogene products in middle ear cholesteatoma]. Holly A; Sittinger M; Bujía J Laryngorhinootologie; 1995 Jun; 74(6):348-51. PubMed ID: 7662077 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma. Holly A; Sittinger M; Bujia J Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157 [TBL] [Abstract][Full Text] [Related]
3. [Expression of calgranulin A and B in middle ear cholesteatoma]. Holly A; Bujía J; Lempart K; Serge M Laryngorhinootologie; 1995 Jan; 74(1):33-5. PubMed ID: 7888019 [TBL] [Abstract][Full Text] [Related]
4. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death. Shinoda H; Huang CC Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882 [TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of TERT and c-Myc oncogene protein product on cholesteatoma epithelium]. Zhang F; Liu J; Yuan T; Liu Q; Han Z; Wang S; Zhang C; Chen S Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):302-4. PubMed ID: 16001896 [TBL] [Abstract][Full Text] [Related]
6. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium. Kojima H; Miyazaki H; Tanaka Y; Shiwa M; Koga T; Moriyama H Arch Otolaryngol Head Neck Surg; 1999 Jul; 125(7):738-42. PubMed ID: 10406309 [TBL] [Abstract][Full Text] [Related]
7. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin. Sudhoff H; Bujía J; Fisseler-Eckhoff A; Holly A; Schulz-Flake C; Hildmann H Laryngoscope; 1995 Nov; 105(11):1227-31. PubMed ID: 7475881 [TBL] [Abstract][Full Text] [Related]
8. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67. Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533 [TBL] [Abstract][Full Text] [Related]
9. Survival signaling and terminal differentiation in cholesteatoma epithelium. Huisman MA; De Heer E; Grote JJ Acta Otolaryngol; 2007 Apr; 127(4):424-9. PubMed ID: 17453465 [TBL] [Abstract][Full Text] [Related]
10. Cycline-dependent kinase inhibitor, p27 (KIP1), is associated with cholesteatoma. Bayazít YA; Karakök M; Uçak R; Kanlíkama M Laryngoscope; 2001 Jun; 111(6):1037-41. PubMed ID: 11404617 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study on proliferative activity of experimental cholesteatoma. Park K; Park HJ; Chun YM Eur Arch Otorhinolaryngol; 2001 Mar; 258(3):101-5. PubMed ID: 11374247 [TBL] [Abstract][Full Text] [Related]
15. [The expression of Ras protein in human middle ear cholesteatoma]. Xu Y; Jin K; Dong W Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851 [TBL] [Abstract][Full Text] [Related]
16. Terminal differentiation of epithelial cells in middle ear cholesteatoma: investigation of patterns of expression of protein kinase C-delta and protein kinase C-eta. Miyazaki H; Kojima H; Tanaka Y; Shiwa M; Koga T; Moriyama H Laryngoscope; 1999 Nov; 109(11):1785-92. PubMed ID: 10569408 [TBL] [Abstract][Full Text] [Related]